pre-miRNA Information
pre-miRNA hsa-mir-4745   
Genomic Coordinates chr19: 804940 - 805001
Description Homo sapiens miR-4745 stem-loop
Comment None
RNA Secondary Structure

Mature miRNA Information
Mature miRNA hsa-miR-4745-5p
Sequence 2| UGAGUGGGGCUCCCGGGACGGCG |24
Evidence Experimental
Experiments Illumina
DRVs in miRNA
Mutant ID Mutant Position Mutant Source
COSM6231418 6 COSMIC
COSN9853232 19 COSMIC
SNPs in miRNA
Mutant ID Mutant Position Mutant Source
rs1383282684 5 dbSNP
rs1397680926 5 dbSNP
rs569478349 7 dbSNP
rs1370492118 8 dbSNP
rs773676198 9 dbSNP
rs1163342742 10 dbSNP
rs1364058972 13 dbSNP
rs374562787 14 dbSNP
rs771228280 15 dbSNP
rs10422347 19 dbSNP
rs759808148 20 dbSNP
rs765171167 21 dbSNP
rs147466582 22 dbSNP
rs139864698 23 dbSNP
Putative Targets

miRNA Expression profile
Human miRNA Tissue Atlas
miRNAs in Extracellular Vesicles
Circulating MicroRNA Expression Profiling
Gene Information
Gene Symbol SETD1B
Experimental Support 1 for Functional miRNA-Target Interaction
miRNA:Target ----
Validation Method
Conditions TZM-bl
Location of target site 3'UTR
Tools used in this research TargetScan , miRTarCLIP , Piranha
Original Description (Extracted from the article) ... PAR-CLIP data was present in GSM1462574. RNA binding protein: AGO2. Condition:TZM-bl ami BaL ...

- Whisnant AW; Bogerd HP; Flores O; Ho P; et al., 2013, mBio.

miRNA-target interactions (Provided by authors)
ID Duplex structure Position
1
miRNA  3' gcggcagggcccucgGGGUGAGu 5'
                         ||||||| 
Target 5' ----------cuucaCCCACUCa 3'
1 - 13
2
miRNA  3' gcGGCAGGGCCCUCGGGGUG-AGU 5'
            ||  |||   | |||||| || 
Target 5' ccCCAACCC-ACA-CCCCACAUCC 3'
15 - 36
Article - Whisnant AW; Bogerd HP; Flores O; Ho P; et al.
- mBio, 2013
UNLABELLED: The question of how HIV-1 interfaces with cellular microRNA (miRNA) biogenesis and effector mechanisms has been highly controversial. Here, we first used deep sequencing of small RNAs present in two different infected cell lines (TZM-bl and C8166) and two types of primary human cells (CD4(+) peripheral blood mononuclear cells [PBMCs] and macrophages) to unequivocally demonstrate that HIV-1 does not encode any viral miRNAs. Perhaps surprisingly, we also observed that infection of T cells by HIV-1 has only a modest effect on the expression of cellular miRNAs at early times after infection. Comprehensive analysis of miRNA binding to the HIV-1 genome using the photoactivatable ribonucleoside-induced cross-linking and immunoprecipitation (PAR-CLIP) technique revealed several binding sites for cellular miRNAs, a subset of which were shown to be capable of mediating miRNA-mediated repression of gene expression. However, the main finding from this analysis is that HIV-1 transcripts are largely refractory to miRNA binding, most probably due to extensive viral RNA secondary structure. Together, these data demonstrate that HIV-1 neither encodes viral miRNAs nor strongly influences cellular miRNA expression, at least early after infection, and imply that HIV-1 transcripts have evolved to avoid inhibition by preexisting cellular miRNAs by adopting extensive RNA secondary structures that occlude most potential miRNA binding sites. IMPORTANCE: MicroRNAs (miRNAs) are a ubiquitous class of small regulatory RNAs that serve as posttranscriptional regulators of gene expression. Previous work has suggested that HIV-1 might subvert the function of the cellular miRNA machinery by expressing viral miRNAs or by dramatically altering the level of cellular miRNA expression. Using very sensitive approaches, we now demonstrate that neither of these ideas is in fact correct. Moreover, HIV-1 transcripts appear to largely avoid regulation by cellular miRNAs by adopting an extensive RNA secondary structure that occludes the ability of cellular miRNAs to interact with viral mRNAs. Together, these data suggest that HIV-1, rather than seeking to control miRNA function in infected cells, has instead evolved a mechanism to become largely invisible to cellular miRNA effector mechanisms.
LinkOut: [PMID: 23592263]
CLIP-seq Support 1 for dataset GSM1462574
Method / RBP PAR-CLIP / AGO2
Cell line / Condition TZM-bl / TZM-bl ami BaL
Location of target site ENST00000267197.5 | 3UTR | CUUCACCCACUCACCCCCAACCCACACCCCACAUCCCCCUG
Tools used in this analysis TargetScan, miRTarCLIP, and Piranha
Article / Accession Series PMID: 23592263 / GSE59944
CLIP-seq Viewer Link
MiRNA-Target Expression Profile
Dataset Pearson Correlation P-value for Pearson Correlation Spearman Correlation P-value for Spearman Correlation Samples Chart
MiRNA-Target Expression Profile (TCGA)
Tumor Pearson Correlation P-value for Pearson Correlation Spearman Correlation P-value for Spearman Correlation Samples Chart
85 hsa-miR-4745-5p Target Genes:
Functional analysis:
ID Target Description Validation methods
Strong evidence Less strong evidence
MIRT100716 TJAP1 tight junction associated protein 1 2 2
MIRT183592 ZC3H11A zinc finger CCCH-type containing 11A 2 2
MIRT338035 DAZAP2 DAZ associated protein 2 2 4
MIRT395801 SPCS3 signal peptidase complex subunit 3 2 2
MIRT443946 LRIT3 leucine rich repeat, Ig-like and transmembrane domains 3 2 2
MIRT450579 HIST1H2BG histone cluster 1 H2B family member g 2 6
MIRT451616 MEIS3P1 Meis homeobox 3 pseudogene 1 2 2
MIRT452330 EIF5AL1 eukaryotic translation initiation factor 5A-like 1 2 2
MIRT453278 EFTUD2 elongation factor Tu GTP binding domain containing 2 2 2
MIRT455213 GNL1 G protein nucleolar 1 (putative) 2 2
MIRT455469 LYPLA2 lysophospholipase II 2 2
MIRT456502 PFKFB2 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 2 2 2
MIRT456686 LDB1 LIM domain binding 1 2 2
MIRT456914 DDA1 DET1 and DDB1 associated 1 2 2
MIRT457602 IDS iduronate 2-sulfatase 2 2
MIRT457849 RNASEH2B ribonuclease H2 subunit B 2 4
MIRT458454 RPRM reprimo, TP53 dependent G2 arrest mediator homolog 2 2
MIRT460178 UNK unkempt family zinc finger 2 6
MIRT461464 SLC19A3 solute carrier family 19 member 3 2 2
MIRT464738 UBE2Q1 ubiquitin conjugating enzyme E2 Q1 2 2
MIRT465278 TRIM28 tripartite motif containing 28 2 2
MIRT468449 SETD1B SET domain containing 1B 2 2
MIRT468619 SUMO1 small ubiquitin-like modifier 1 2 6
MIRT469151 RNF121 ring finger protein 121 2 2
MIRT470072 PTGES2 prostaglandin E synthase 2 2 2
MIRT470171 PSMD11 proteasome 26S subunit, non-ATPase 11 2 4
MIRT473155 MLLT1 MLLT1, super elongation complex subunit 2 2
MIRT474307 LAMC1 laminin subunit gamma 1 2 2
MIRT474781 KIAA0895L KIAA0895 like 2 2
MIRT476482 GATAD2A GATA zinc finger domain containing 2A 2 2
MIRT477612 EFNA3 ephrin A3 2 2
MIRT479523 CDCA4 cell division cycle associated 4 2 2
MIRT479972 CARD10 caspase recruitment domain family member 10 2 2
MIRT480409 C19orf47 chromosome 19 open reading frame 47 2 2
MIRT480425 C17orf85 nuclear cap binding subunit 3 2 2
MIRT483571 SYT2 synaptotagmin 2 2 2
MIRT483663 QSOX2 quiescin sulfhydryl oxidase 2 2 4
MIRT484531 POLD3 DNA polymerase delta 3, accessory subunit 2 2
MIRT484614 SIX3 SIX homeobox 3 2 6
MIRT485896 ZFP36 ZFP36 ring finger protein 2 2
MIRT486504 MYH11 myosin heavy chain 11 2 2
MIRT487506 GRK5 G protein-coupled receptor kinase 5 2 2
MIRT488851 UBTF upstream binding transcription factor, RNA polymerase I 2 2
MIRT489463 MSC musculin 2 2
MIRT491168 LRP3 LDL receptor related protein 3 2 2
MIRT496626 TMEM67 transmembrane protein 67 2 2
MIRT497615 ANG angiogenin 2 2
MIRT497765 KIAA0895 KIAA0895 2 2
MIRT499679 MRE11A MRE11 homolog, double strand break repair nuclease 2 6
MIRT499772 SLC29A2 solute carrier family 29 member 2 2 2
MIRT501744 NSD1 nuclear receptor binding SET domain protein 1 2 2
MIRT504993 ZNF652 zinc finger protein 652 2 2
MIRT511663 HIST1H3C histone cluster 1 H3 family member c 2 2
MIRT511689 HIST1H2BO histone cluster 1 H2B family member o 2 4
MIRT511702 HIST1H2BL histone cluster 1 H2B family member l 2 4
MIRT511733 HIST1H2BE histone cluster 1 H2B family member e 2 8
MIRT512857 TBC1D13 TBC1 domain family member 13 2 2
MIRT513443 EMP1 epithelial membrane protein 1 2 6
MIRT515680 TFPI tissue factor pathway inhibitor 2 2
MIRT523528 GLUL glutamate-ammonia ligase 2 2
MIRT525545 PHB2 prohibitin 2 2 4
MIRT526208 SNX24 sorting nexin 24 2 2
MIRT531555 SRD5A1 steroid 5 alpha-reductase 1 2 2
MIRT533763 TMEM135 transmembrane protein 135 2 2
MIRT545581 SNRPA1 small nuclear ribonucleoprotein polypeptide A' 2 2
MIRT552433 ZNF460 zinc finger protein 460 2 2
MIRT561158 BCL2L12 BCL2 like 12 2 2
MIRT562344 EXOSC2 exosome component 2 2 2
MIRT570658 KDM6B lysine demethylase 6B 2 2
MIRT571075 TCHHL1 trichohyalin like 1 2 2
MIRT571331 TPCN2 two pore segment channel 2 2 2
MIRT571601 TOB2 transducer of ERBB2, 2 2 2
MIRT573012 RPP25 ribonuclease P and MRP subunit p25 2 2
MIRT609042 EP300 E1A binding protein p300 2 2
MIRT613397 DNAH17 dynein axonemal heavy chain 17 2 2
MIRT635588 TTC9C tetratricopeptide repeat domain 9C 2 2
MIRT644753 TXNRD3NB thioredoxin reductase 3 neighbor 2 2
MIRT661117 FPR1 formyl peptide receptor 1 2 2
MIRT690102 PNMA2 paraneoplastic Ma antigen 2 2 2
MIRT694971 PLAC8 placenta specific 8 2 2
MIRT695514 ALPI alkaline phosphatase, intestinal 2 2
MIRT695576 ASB16 ankyrin repeat and SOCS box containing 16 2 2
MIRT699569 SIT1 signaling threshold regulating transmembrane adaptor 1 2 2
MIRT701990 MIER3 MIER family member 3 2 2
MIRT725462 GRAP2 GRB2-related adaptor protein 2 2 2
miRNA-Drug Associations
miRNA Small Melocule FDA CID Detection Method Condition PMID Year Expression Pattern of miRNA
miR-4745-5p Cisplatin approved 84093 Microarray CNE cells 22614822 2012 up-regulated
miRNA-Drug Resistance Associations
miRNA Drug Name CID NSC FDA Effect/Pattern Detection Method Level Phenotype Condition
hsa-mir-4745 Fluorouracil 3385 NSC19893 approved resistant High Pancreatic Cancer cell line (PANC-1)
hsa-mir-4745 Gemcitabine 60750 NSC613327 approved resistant High Pancreatic Cancer cell line (PANC-1)
hsa-mir-4745 Plx-4720 24180719 NSC757438 sensitive High Thyroid Cancer cell line (8505c, BCPAP)
hsa-mir-4745 Ceritinib 57379345 NSC776422 approved sensitive High Non-Small Cell Lung Cancer cell line (H3122, H2228)
hsa-mir-4745 Dabrafenib 44462760 NSC764134 approved resistant cell line (A375)
hsa-mir-4745 Androstenedione+Anastrozole sensitive cell line (MCF-7)
hsa-mir-4745 Ceritinib 57379345 NSC776422 approved sensitive cell line (H3122)
hsa-miR-4745-5p Platinum 23939 sensitive High Ovarian Cancer tissue
hsa-miR-4745-5p Dabrafenib 44462760 NSC764134 approved resistant High Melanoma cell line (A375, IGR37, 501Mel)
hsa-miR-4745-5p Vemurafenib 42611257 NSC761431 approved resistant High Melanoma cell line (A375, IGR37, 501Mel)
hsa-miR-4745-5p Doxorubicin 31703 NSC123127 approved sensitive High Breast Cancer cell line (MCF-7)
hsa-miR-4745-5p Curcumin 969516 NSC32982 approved sensitive High Breast Cancer cell line (MCF-7)
hsa-miR-4745-5p Fulvestrant 17756771 NSC719276 approved resistant High Breast Cancer cell line (MCF-7)
hsa-miR-4745-5p Ceritinib 57379345 NSC776422 approved sensitive High Non-Small Cell Lung Cancer cell line (H3122, H2228)
hsa-miR-4745-5p Paclitaxel 36314 NSC125973 approved resistant High Non-Small Cell Lung Cancer cell line (H460)
hsa-miR-4745-5p Docetaxel 148124 NSC628503 approved sensitive High Breast Cancer cell line (MDA-MB-231, MCF-7)
hsa-miR-4745-5p Gefitinib 123631 NSC715055 approved sensitive cell line (PC9)
hsa-miR-4745-5p Gefitinib 123631 NSC715055 approved sensitive cell line (HCC827)
hsa-miR-4745-5p Osimertinib 71496458 NSC779217 approved sensitive cell line (HCC827)
hsa-miR-4745-5p Cisplatin 5460033 NSC119875 approved resistant cell line (CAL-27) (cytosolic RNA)
hsa-miR-4745-5p Cisplatin 5460033 NSC119875 approved resistant cell line (CAL-27) (total RNA)
hsa-miR-4745-5p Cisplatin 5460033 NSC119875 approved sensitive cell line
hsa-miR-4745-5p Cisplatin 5460033 NSC119875 approved sensitive cell line (A549)
hsa-miR-4745-5p Gefitinib 123631 NSC715055 approved resistant cell line (HCC827)
hsa-miR-4745-5p Doxorubicin 31703 NSC123127 approved resistant cell line (HS578T)
hsa-miR-4745-5p Doxorubicin 31703 NSC123127 approved resistant cell line (BAS)
hsa-miR-4745-5p Tamoxifen+Fulvestrant sensitive cell line (LCC9)
hsa-miR-4745-5p Osimertinib 71496458 NSC779217 approved sensitive cell line (H1975)
hsa-miR-4745-5p Gemcitabine 60750 NSC613327 approved resistant cell line (MDA-231)
hsa-miR-4745-5p Gemcitabine 60750 NSC613327 approved sensitive cell line (PANC-1) (1500 ng/ml)
hsa-miR-4745-5p Gemcitabine 60750 NSC613327 approved sensitive cell line (PANC-1) (100 ng/ml)
hsa-miR-4745-5p Ceritinib 57379345 NSC776422 approved sensitive cell line (H3122)

Error report submission